Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Interim Management Statement

7 Nov 2008 07:00

RNS Number : 6725H
Stanelco PLC
07 November 2008
 



7th November 2008

STANELCO PLC ("the Company" or "the Group")

Interim Management Statement

The Board of Stanelco Plc today issues its interim management statement for the nine month period ended 30 September 2008.

Overview

The first nine months of the year saw 120% growth in sales revenue to £12.2m compared with the same period last year (2007: £5.6m). We continued to make progress in reducing our operating losses.

Divisional Performance

BioPlastics

Commercialisation of the bioplastics technology continues as the Company broadens its base of regular customers, which is now developed across a variety of European markets.

Sales of bioplastics, made directly by Stanelcoare now up 450compared to the same 9 month period last year. Direct sales in the third quarter were up 24% on the second quarter, reaching £1.4m year-to-date.

In the third quarter the Company opened a small sales office in the USA to begin the process of exploiting the emerging opportunity for sustainable bioplastics in North America. This renewed activity is being driven by an experienced plastics industry professional and is already creating an encouraging pipeline of trials.

We have continued to strengthen the BioPlastics division in the UK by recruiting further senior technical and customer support expertise with substantive relevant expertise.  

Further minor investment in development and testing equipment was also made at the UK development facility in the period. Development trials continue to establish pace and laboratory success, with a number of new products having moved to pre-commercial trials with several customers.

RF Applications

In RF Applications divisionthe strong enquiry book is gradually being converted into orders and we expect to see some benefit of that in the second half as the General Manager and newly appointed Sales Manager begin to achieve traction.

The optical fiber furnace market continues to show encouraging signs, driven by continued fiber demand in Asia. In the third quarter, Stanelco continued to strengthen its position in China with its first order for its new generation of higher capacity furnaces powered by Stanelco's new RF generator.

There is also growing interest in the newly developed mobile welding products. However, the long lead times from enquiry to order mean that this is likely to have limited impact on this financial year's results.

Financial Position

We continue to maintain a strong balance sheet. Our cash position at 30 September was £6.9mstrengthened since the half year by working capital movements related to stock reduction.

Outlook 

Our strategy is clear and good progress is being made. We continue to look for compatible and sensible investment opportunities.

We remain alert to the rapidly changing economic conditions throughout the worldbut we have not seen an impact on our business as yet. The Board's expectations for the financial performance for 2008 remain in line with those set earlier in the year.

Ends -

Paul Mines, Chief Executive, Stanelco plc

Clive Warner, Finance Director, Stanelco plc

Tel: +44 (0) 2380 867 100

Jonathon Brill/Caroline Stewart

Financial Dynamics

Tel: +44 (0) 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBFBPTMMIMBBP
Date   Source Headline
21st Mar 20257:00 amRNSCancellation- Biome Technologies PLC
13th Mar 202512:22 pmRNSResult of GM & update on Cancellation
21st Feb 20257:00 amRNSProposed Cancellation & Notice of GM
18th Dec 20247:00 amRNSSecured Funding Facility
4th Dec 20247:00 amRNSTrading Update and Board Change
13th Nov 20247:00 amRNSTrading Update
25th Oct 20247:00 amRNSAppointment of Non-Executive Director
30th Sep 20245:00 pmRNSTotal Voting Rights
30th Sep 202411:08 amRNSContract win for Stanelco RF Division
20th Sep 20247:00 amRNSInterim Results
13th Sep 202410:58 amRNSHolding(s) in Company
12th Sep 202411:43 amRNSHolding(s) in Company
11th Sep 20243:01 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20244:51 pmRNSHolding(s) in Company
4th Sep 20242:39 pmRNSResult of General Meeting and TVR
30th Aug 20245:00 pmRNSTotal Voting Rights
23rd Aug 20242:42 pmRNSHolding(s) in Company
22nd Aug 202411:00 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSResult of Retail Offer, Director dealing and TVR
21st Aug 20244:12 pmRNSHolding(s) in Company
21st Aug 20241:41 pmRNSHolding(s) in Company
16th Aug 20247:05 amRNSRetail offer to raise up to £80,000
16th Aug 20247:01 amRNSProposed Fundraise and other matters
16th Aug 20247:00 amRNSTrading update
10th Jul 20247:00 amRNSDirectorate Change
8th Jul 20247:00 amRNSTrading update
12th Jun 20247:00 amRNSGrant of Options
29th May 202410:57 amRNSResult of AGM, Interim CFO and Directorate Change
22nd May 20242:27 pmRNSContract win for Stanelco RF Division
15th May 20247:00 amRNSNotice of AGM and 2023 Annual Report
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.